Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ)
CNY 7.84
(0.38%)
CNY 7.84
(0.38%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 180.38 Million CNY | -41.36% |
| 2022 | 307.6 Million CNY | 152.9% |
| 2021 | 121.63 Million CNY | -55.22% |
| 2020 | 271.61 Million CNY | 63.17% |
| 2019 | 166.46 Million CNY | 46.1% |
| 2018 | 113.93 Million CNY | -17.86% |
| 2017 | 138.69 Million CNY | -9.66% |
| 2016 | 153.53 Million CNY | 47.03% |
| 2015 | 104.42 Million CNY | 24.07% |
| 2014 | 84.16 Million CNY | 64.97% |
| 2013 | 51.01 Million CNY | -15.58% |
| 2012 | 60.42 Million CNY | 47.62% |
| 2011 | 40.93 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 36.98 Million CNY | 412.79% |
| 2024 Q2 | 4.91 Million CNY | -86.72% |
| 2024 Q3 | 58.33 Million CNY | 1087.49% |
| 2023 Q4 | -11.82 Million CNY | 47.89% |
| 2023 FY | 180.38 Million CNY | -41.36% |
| 2023 Q1 | 199.06 Million CNY | 190.43% |
| 2023 Q2 | -880.02 Thousand CNY | -100.44% |
| 2023 Q3 | -22.69 Million CNY | -2478.59% |
| 2022 Q4 | 68.54 Million CNY | -50.61% |
| 2022 FY | 307.6 Million CNY | 152.9% |
| 2022 Q3 | 138.77 Million CNY | 464.62% |
| 2022 Q2 | -38.05 Million CNY | -159.76% |
| 2022 Q1 | 63.69 Million CNY | -45.03% |
| 2021 FY | 121.63 Million CNY | -55.22% |
| 2021 Q2 | -29.38 Million CNY | -167.74% |
| 2021 Q3 | -46.5 Million CNY | -58.27% |
| 2021 Q1 | 43.37 Million CNY | -38.85% |
| 2021 Q4 | 115.87 Million CNY | 349.16% |
| 2020 Q1 | 77.86 Million CNY | 126.06% |
| 2020 Q3 | 62.52 Million CNY | 415.83% |
| 2020 Q2 | -19.79 Million CNY | -125.42% |
| 2020 FY | 271.61 Million CNY | 63.17% |
| 2020 Q4 | 70.92 Million CNY | 13.44% |
| 2019 Q3 | -10.43 Million CNY | 42.29% |
| 2019 Q2 | -18.08 Million CNY | -126.68% |
| 2019 Q1 | 67.77 Million CNY | 949.12% |
| 2019 FY | 166.46 Million CNY | 46.1% |
| 2019 Q4 | 34.44 Million CNY | 430.06% |
| 2018 Q3 | 72.58 Million CNY | 239.87% |
| 2018 FY | 113.93 Million CNY | -17.86% |
| 2018 Q1 | 89.61 Million CNY | 99.92% |
| 2018 Q4 | 6.46 Million CNY | -91.1% |
| 2018 Q2 | -51.89 Million CNY | -157.91% |
| 2017 Q1 | 43 Million CNY | 12.1% |
| 2017 FY | 138.69 Million CNY | -9.66% |
| 2017 Q3 | 38.98 Million CNY | 227.88% |
| 2017 Q4 | 44.82 Million CNY | 14.99% |
| 2017 Q2 | 11.88 Million CNY | -72.36% |
| 2016 Q3 | 42.73 Million CNY | 405.37% |
| 2016 FY | 153.53 Million CNY | 47.03% |
| 2016 Q4 | 38.36 Million CNY | -10.24% |
| 2016 Q2 | -13.99 Million CNY | -116.19% |
| 2016 Q1 | 86.42 Million CNY | 111.08% |
| 2015 Q2 | -9.11 Million CNY | -120.44% |
| 2015 Q1 | 44.61 Million CNY | 39.95% |
| 2015 FY | 104.42 Million CNY | 24.07% |
| 2015 Q4 | 40.94 Million CNY | 46.35% |
| 2015 Q3 | 27.97 Million CNY | 406.84% |
| 2014 FY | 84.16 Million CNY | 64.97% |
| 2014 Q3 | 20.21 Million CNY | 213.32% |
| 2014 Q1 | 49.9 Million CNY | 0.0% |
| 2014 Q4 | 31.88 Million CNY | 57.73% |
| 2014 Q2 | -17.83 Million CNY | -135.74% |
| 2013 FY | 51.01 Million CNY | -15.58% |
| 2012 FY | 60.42 Million CNY | 47.62% |
| 2011 FY | 40.93 Million CNY | 0.0% |